Clinical trials
Completed Phase 1 Hematologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 4 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 11 |
| Apellis Pharmaceuticals, Inc. | 2 |
| Baylor College of Medicine | 2 |
| Novartis Pharmaceuticals | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Bioverativ, a Sanofi company | 1 |
| Cellphire Therapeutics, Inc. | 1 |
| Chroma Therapeutics | 1 |
| Eli Lilly and Company | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 39 |
| Lymphoma | 12 |
| Multiple Myeloma | 8 |
| Lymphoma, Non-Hodgkin | 7 |
| Neoplasms | 7 |
| Hematologic Neoplasms | 5 |
| Hodgkin Disease | 5 |
| Immunoproliferative Disorders | 5 |
| Lymphoma, Large-Cell, Anaplastic | 5 |
| Lymphoproliferative Disorders | 5 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.